Yarrow Bioscience Inc (YARW) Stock

NASDAQ: YARWHealthcare company in the biotechnology industry, based in New York, NY.

Yarrow Bioscience stock price chart

YARW interactive chart →

YARW stock quote & key statistics

Yarrow Bioscience earnings per share

Income →
Earnings per share

Yarrow Bioscience revenue & net income

Income →
RevenueNet income

Yarrow Bioscience annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$570,000-$26.5M—
FY2024$501,000-$39.8M-$46.77
FY2023$424,000-$28.5M-$350.23
FY2022$477,000-$23.2M-$369.34
FY2021$931,000-$73.3M-$1289.99

Fiscal year ending December 31. Source: company filings via EODHD.

About Yarrow Bioscience Inc

Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.

Yarrow Bioscience stock FAQ

What is the Yarrow Bioscience stock ticker symbol?

Yarrow Bioscience Inc trades on the NASDAQ under the ticker symbol YARW.

What sector and industry is Yarrow Bioscience in?

Yarrow Bioscience Inc is classified in the Healthcare sector, Biotechnology industry.

How many employees does Yarrow Bioscience have?

Yarrow Bioscience Inc has about 7 full-time employees.

What were Yarrow Bioscience's revenue and earnings last fiscal year?

Yarrow Bioscience reported revenue of $570,000 and net income of -$26.5M in fiscal 2025. Revenue grew 13.8% from the prior year.

When did Yarrow Bioscience go public?

Yarrow Bioscience stock began trading on January 25, 2018.

Biotechnology stocks

All Healthcare stocks →